Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: Report of three cases and review of the literature

Annals of Pharmacotherapy

Volumn 44, Issue 4, 2010, Pages 740-745

  Chang, Brenda ^a,b   Knowles, Sandra R ^c   Weber, Elizabeth ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Anaphylaxis; Ciprofloxacin; Cross reactions; Fluoroquinolones; Hypersensitivity; Immediate; Moxifloxacin

Indexed keywords

ADRENALIN; CETIRIZINE; CIPROFLOXACIN; DIPHENHYDRAMINE; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLONE DERIVATIVE;

ADULT; AGED; ANAPHYLAXIS; ANTIGEN SPECIFICITY; ARTICLE; BRONCHIECTASIS; CASE REPORT; CROSS REACTION; DISEASE EXACERBATION; DIZZINESS; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HOT FLUSH; HUMAN; HYPOTENSION; MALE; NAUSEA; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PRURITUS; RATING SCALE; SELF MEDICATION; SKIN TEST; URTICARIA; VOMITING; WEAKNESS; WHEEZING;

ADULT; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BRONCHIECTASIS; CIPROFLOXACIN; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MIDDLE AGED; QUINOLINES; SKIN TESTS; URTICARIA;

EID: 77950618271     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M579     Document Type: Article

References (47)

1. Van Bambeke F, Michot JM, Van Eldere J, Tulkens PM. Quinolones in 2005: an update. Clin Microbiol Infect 2005;11:256-280 DOI 10.1111/j.1469-0691.2005. 01131.x (Pubitemid 40443832)
2. Appelbaum PC, Hunter PA. The fluoroquinolone antibacterials: past, present and future perspectives. Int J Antimicrob Agents 2000;16:5-15. DOI 10.1016/S0924-8579(00)00192-8 (Pubitemid 30665419)
3. Ball P. Adverse drug reactions: implications for the development of fluo- roquinolones. J Antimicrob Chemother 2003;51(suppl 1):21-27 DOI 10.1093/jac/dkg209 (Pubitemid 36622101)
4. Bertino J Jr, Fish D. The safety profile of the fluoroquinolones. Clin Ther 2000;22:798-817. DOI 10.1016/S0149-2918(00)80053-3 (Pubitemid 30625913)
5. De Sarro A, De Sarro G. Adverse reactions to fluoroquinolones. an overview on mechanistic aspects. Curr Med Chem 2001;8:371-384 (Pubitemid 32409786)
6. Mehlhorn AJ, Brown DA. Safety concerns with fluoroquinolones. Ann Pharmacother 2007;41:1859-1866 DOI 10.1345/aph.1K347 (Pubitemid 350044349)
7. Campi P, Pichler WJ. Quinolone hypersensitivity. Curr Opin Allergy Clin Immunol 2003;3:275-281 DOI 10.1097/00130832-200308000-00007 (Pubitemid 37010883)
8. Scherer K, Bircher AJ. Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep 2005;5:15-21. DOI 10.1007/s11882-005-0049-1 (Pubitemid 40310252)
9. Van Bambeke F, Tulkens PM. Safety profile of the respiratory fluoroquinolone moxifloxacin. Drug Saf 2009;32:359-378 DOI 10.2165/00002018- 200932050-00001
10. Alemán AM, Quirce S, Cuesta J, Novalbos A, Sastre J. Anaphylactoid reaction caused by moxifloxacin. J Investig Allergol Clin Immunol 2002; 12:67-68 (Pubitemid 34507071)
11. González I, Lobera T, Blasco A, del Pozo MD. Immediate hypersensitivity to quinolones: moxifloxacin cross-reactivity. J Investig Allergol Clin Immunol 2005;15:146-149 (Pubitemid 41020177)
12. Sachs B, Riegel S, Seebeck J, et al. Fluoroquinolone-associated anaphy- laxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Drug Saf 2006;29:1087-1100 DOI 10.2165/00002018-200629110-00008 (Pubitemid 44912717)
13. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245 (Pubitemid 12149145)
14. Kothur K, Singh M, Dayal D. Ciprofloxacin-induced anaphylactoid reaction. Eur J Pediatr 2006;165:573-574 DOI 10.1007/s00431-006-0099-y (Pubitemid 43989419)
15. Ho DY, Song JC, Wang CC. Anaphylactoid reaction to ciprofloxacin. Ann Pharmacother 2003;37:1018-1023 DOI 10.1345/aph.1C498
16. Burke P, Burne SR. Allergy associated with ciprofloxacin. BMJ 2000;320:679. DOI 10.1136/bmj.320.7236.679 (Pubitemid 30179392)
17. Erdem G, Staat MA, Connelly BL, Assa'ad A. Anaphylactic reaction to ciprofloxacin in a toddler: successful desensitization. Pediatr Infect Dis J 1999;18:563-564 DOI 10.1097/00006454-199906000-00022 (Pubitemid 29277629)
18. Clutterbuck DJ, McMillan A. Anaphylactoid reaction to ciprofloxacin. Int J STD AIDS 1997;8:707-708 DOI 10.1258/0956462971918931 (Pubitemid 28083445)
19. Salon EJ, Newbrough MA, Albarracin CA, Hernandez JE. Anaphylac- toid reaction to ciprofloxacin versus toxic shock syndrome (letter). Ann Pharmacother 1997;31:119-120
20. Vidal C, Suarez J, Martinez M, Gonzalez-Quintela A. Ciprofloxacin-in- duced glottic angioedema (letter). Postgrad Med J 1995;71:318. DOI 10.1136/pgmj.71.835.318-a
21. Assouad M, Willcourt RJ, Goodman PH. Anaphylactoid reactions to ciprofloxacin (letter). Ann Intern Med 1995;122:396-397
22. Soetikno RM, Johnson JL, Carey JT. Ciprofloxacin-induced anaphylac- toid reaction in a patient with AIDS (letter). Ann Pharmacother 1993; 27:1404.
23. Deamer RL, Prichard JG, Loman GJ. Hypersensitivity and anaphylactoid reactions to ciprofloxacin. Ann Pharmacother 1992;26:1081-1084
24. Berger TG, Franklin N. Anaphylactoid reaction to ciprofloxacin in a patient infected with the human immunodeficiency virus. J Am Acad Dermatol 1992;26:256-257 DOI 10.1016/S0190-9622(08)80302-7
25. Miller MS, Gaido F, Rourk MH Jr, Spock A. Anaphylactoid reactions to ciprofloxacin in cystic fibrosis patients. Pediatr Infect Dis J 1991;10:164-165 DOI 10.1097/00006454-199102000-00020
26. Kennedy CA, Goetz MB, Mathisen GE. Ciprofloxacin-induced anaphy- lactoid reactions in patients infected with the human immunodeficiency virus (letter). West J Med 1990;153:563-564
27. Davis H, McGoodwin E, Reed TG. Anaphylactoid reactions reported after treatment with ciprofloxacin. Ann Intern Med 1989;111:1041-1043 (Pubitemid 20034930)
28. Wurtz RM, Abrams D, Becker S, Jacobson MA, Mass MM, Marks SH. Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-in-fected patients (letter). Lancet 1989;1:955-956 DOI 10.1016/S0140-6736(89)92529-4 (Pubitemid 19126900)
29. Peters B, Pinching AJ. Fatal anaphylaxis associated with ciprofloxacin in a patient with AIDS related complex (letter). BMJ 1989;298:605. DOI 10.1136/bmj.298.6673.605-b
30. Baciewicz AM, Georges G, Becker M, Schnall AM. Laryngeal edema related to ciprofloxacin therapy (letter). Ann Pharmacother 1992;26: 1456.
31. Burks EJ. Norfloxacin hypersensitivity (letter). DICP 1989;23:90.
32. Desai C, Desai KJ, Shah UH. Ofloxacin induced hypersensitivity reaction. J Assoc Physicians India 1999;47:349.
33. Smythe MA, Cappelletty DM. Anaphylactoid reaction to levofloxacin. Pharmacotherapy 2000;20:1520-1523 DOI 10.1592/phco.20.19.1520.34868
34. Takahama H, Tsutsumi Y, Kubota Y. Anaphylaxis due to levofloxacin. Int J Dermatol 2005;44:789-790 DOI 10.1111/j.1365-4632.2004.02325.x (Pubitemid 41301020)
35. González-Mancebo E, Fernández-Rivas M. Immediate hypersensitivity to levofloxacin diagnosed through skin prick test (letter). Ann Pharma- cother 2004;38:354. DOI 10.1345/aph.1D159 (Pubitemid 38112258)
36. Stricker BH, Slagboom G, Demaeseneer R, Slootmaekers V, Thijs I, Ols- son S. Anaphylactic reactions to cinoxacin. BMJ 1988;297:1434-1435 DOI 10.1136/bmj.297.6661.1434 (Pubitemid 19000174)
37. Valdivieso R, Pola J, Losada E, Subiza J, Armentia A, Zapata C. Severe anaphylactoid reaction to nalidixic acid. Allergy 1988;43:71-73 DOI 10.1111/j.1398-9995.1988.tb02046.x (Pubitemid 18058176)
38. Dávila I, Diez ML, Quirce S, Fraj J, De La Hoz B, Lazaro M. Cross-reactivity between quinolones. Report of three cases. Allergy 1993;48:388-390 DOI 10.1111/j.1398-9995.1993.tb02413.x.
39. al-Hedaithy MA, Noreddin AM. Hypersensitivity anaphylactoid reaction to pefloxacin in a patient with AIDS. Ann Pharmacother 1996;30:612-614 (Pubitemid 26181703)
40. Umebayashi Y, Furuta J. Anaphylaxis due to tosufloxacin tosilate (letter). J Dermatol 2003;30:701-702 (Pubitemid 37229272)
41. Blayac JP, Hillaire-Buys D, Pinzani V. Fluoroquinolones and anaphylax- is. Therapie 1996;51:417-418
42. Manfredi M, Severino M, Testi S, et al. Detection of specific IgE to quinolones. J Allergy Clin Immunol 2004;113:155-160 DOI 10.1016/j.jaci.2003.09. 035 (Pubitemid 38096176)
43. Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 2005;115:1048-1057 DOI 10.1542/peds.2004-1276
44. Pichichero ME. Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift. Diagn Microbiol Infect Dis 2007;57:13S-8S. DOI 10.1016/j.diagmicrobio.2006.12.004 (Pubitemid 46349492)
45. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med. 2001;345:804-809 DOI 10.1056/NEJMra993637
46. Andersson MI, MacGowan AP. Development of the quinolones. J An- timicrob Chemother 2003;51(suppl 1): 1-11. DOI 10.1093/jac/dkg212
47. Higgins PG, Fluit AC, Schmitz FJ. Fluoroquinolones: structure and target sites. Curr Drug Targets 2003;4:181-190 DOI 10.2174/1389450033346920 (Pubitemid 36553588)